Previous 10 | Next 10 |
Innovation, R&D and an aging population are long-term secular trends that will provide a tailwind to the biotechnology sector. The Insurgent AI Deep Innovation Model uses Deep Learning and secular tailwinds to generate alpha. Evaluating investment strategies is challenging, es...
Gainers: [[MTRX]] +13.1%. [[DSWL]] +8.7%. [[STRO]] +6.9%. [[GIFI]] +3.3%. [[PRQR]] +3%.Losers: [[FHTX]] -6.8%. [[CRBP]] -3%. [[PRAX]] -2.8%. [[AAME]] -2.6%. [[BDSI]] -2.6%. For further details see: CRBP, BDSI, PRQR and MTRX among after-hours movers
The following slide deck was published by Corbus Pharmaceuticals Holdings, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Corbus Pharmaceuticals Holdings, Inc. 2020 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) Q4 2020 Earnings Call Mar 15, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2020 ...
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2020 Results Conference Call March 15, 2021 8:30 AM ET Company Participants Ted Jenkins - Senior Director, Investor Relations and Communications Yuval Cohen - Chief Executive Officer and Director Barbara White - Chief Medical Officer and Head of...
Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020. The company said that revenue from awards and licenses was $700,000 for the quarter ending December 31, 2020, ve...
Corbus Pharmaceuticals (CRBP) said that it is actively engaging with potential partners to expand its pipeline through acquisition of external assets, and talked up its cash position by predicting a runway into 2024. Shares up nearly 6% premarket.Corbus als...
Corbus Pharmaceuticals (CRBP): Q4 GAAP EPS of -$0.10 beats by $0.13.Revenue of $0.66M (-74.3% Y/Y) misses by $0.83M.Press Release For further details see: Corbus Pharmaceuticals EPS beats by $0.13, misses on revenue
Norwood, MA, March 15, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today r...
• Company to host conference call and webcast on Monday, March 15, 2021 at 8:30 a.m. ET Norwood, MA, March 08, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-s...
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
Corbus Pharmaceuticals Holdings Inc. Website:
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
2024-07-16 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...